Reunion Neuroscience (TSX:REUN) Accounts Payable & Accrued Expense : C$5.08 Mil (As of Mar. 2023)

View and export this data going back to 2020. Start your Free Trial

What is Reunion Neuroscience Accounts Payable & Accrued Expense?

Reunion Neuroscience's quarterly accounts payable & accrued expense increased from Sep. 2022 (C$3.53 Mil) to Dec. 2022 (C$4.42 Mil) and increased from Dec. 2022 (C$4.42 Mil) to Mar. 2023 (C$5.08 Mil).

Reunion Neuroscience's annual accounts payable & accrued expense increased from Mar. 2021 (C$5.35 Mil) to Mar. 2022 (C$5.85 Mil) but then declined from Mar. 2022 (C$5.85 Mil) to Mar. 2023 (C$5.08 Mil).

Reunion Neuroscience Accounts Payable & Accrued Expense Historical Data

The historical data trend for Reunion Neuroscience's Accounts Payable & Accrued Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Reunion Neuroscience Accounts Payable & Accrued Expense Chart

Reunion Neuroscience Annual Data

Trend

Mar20

Mar21

Mar22

Mar23

Accounts Payable & Accrued Expense

0.58

5.35

5.85

5.08

Reunion Neuroscience Quarterly Data
	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23
Accounts Payable & Accrued Expense	Get a 7-Day Free Trial										5.85	1.04	3.53	4.42	5.08

Reunion Neuroscience Accounts Payable & Accrued Expense Calculation

Accounts payable & accrued expense usually includes accounts payable, accrued compensation and related benefits, etc.

Accounts payable is money owed by a business to its suppliers shown as a liability on a company's balance sheet. It is distinct from notes payable liabilities, which are debts created by formal legal instrument documents.

It is part of the current portion of the liabilities (due within one year or within the normal operating cycle if longer) reflected on the balace sheet of the company. A higher Accounts Payable means lower Working Capital needed to operate the business.

Reunion Neuroscience (TSX:REUN) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Reunion Neuroscience Inc (TSX:REUN) » Definitions » Accounts Payable & Accrued Expense

Comparable Companies

Traded in Other Exchanges

N/A

Address

30 Duncan Street, Lower North Suite, Toronto, ON, CAN, M5V 2C3

Website

https://www.reunionneuro.com

Reunion Neuroscience Inc is engaged in novel psychedelic drug development, committed to innovating therapeutic solutions for mental health conditions by developing proprietary serotonin receptor agonist compounds. The company's asset, RE-104 (previously known as FT-104), is a proprietary, novel psychedelic drug being developed for post-partum and treatment-resistant depression as a potential fast-acting antidepressant with durable efficacy.